A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets

<div>YY1 is highly expressed in many types of tumors. Immunohistochemistry was performed with rabbit polyclonal antibody HPA001119 (Sigma Aldrich).</div>

Journal of Immunology Research

fig2

Figure 2

Figure 2: A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets 

Figure 2 | A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets 